EP2564872
Mazindol alone or in combination with iron for the treatment of attention-deficit/hyperactivity disorder
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.4.2007EP published:
10.6.2020EP application number:
12189703.7
EPO information:
European Patent Register
Max expiry date:
10.4.2027
Title:
Mazindol alone or in combination with iron for the treatment of attention-deficit/hyperactivity disorder
Timeline
Today
11.4.2007EP application
10.6.2020EP Publication
Owner
Name:
NLS Pharmaceutics AGAddress:
Alter Postplatz 2, 6370 Stans, CH
Inventor
Name:
Konofal, EricAddress:
60300 Senlis, FR
Priority
Number:
0603197Date:
11.4.2006Country:
FR
Classification
Categories:
A61K 31/4188, A61K 33/26, A61P 25/26